Concomitant expression of adrenomedullin and its receptor components in rat adipose tissues
- 1 January 2005
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Endocrinology and Metabolism
- Vol. 288 (1), E56-E62
- https://doi.org/10.1152/ajpendo.00586.2003
Abstract
Adrenomedullin (AM) expressed by and secreted from a variety of cells plays pluripotent roles in an autocrine/paracrine fashion. The present study was undertaken to explore the expression of AM and its receptor genes in adipose tissues, their changes during the development of obesity, and the process of preadipocyte differentiation. Both mature adipocytes and stromal vascular cells constituting adipose tissue expressed AM transcript. AM and its receptor component [calcitonin receptor-like receptor and receptor activity-modifying protein-2 (CRLR/RAMP2)] mRNAs were expressed in a variety of rat adipose tissues, including epididymal, mesenteric, retroperitoneal, and subcutaneous adipose tissue. AM mRNA levels in rat and human epididymal adipose tissue were about one-tenth of those in the kidney. Steady-state mRNA levels of AM and CRLR/RAMP2 in epididymal, mesenteric, and retroperitoneal adipose tissues in rats fed a high-fat diet for 4 wk were far greater than those in rats with normal diet accompanied by increased plasma AM levels, whereas steady-state AM mRNA levels conversely decreased in other organs, such as kidney and liver. AM mRNA expressed in a mouse preadipocyte cell line (3T3-L1) transiently decreased by day 3, returned to basal level by day 6, and then increased by day 9 during preadipocyte differentiation, which paralleled AM secretion from the cells. However, the addition of either exogenous AM or AM receptor antagonist calcitonin gene-related peptide-(8–37), to block endogenous AM did not affect lipid droplet accumulation during preadipocyte differentiation. The present study demonstrates for the first time that AM and its receptor component (CRLR/RAMP2) mRNAs were concomitantly expressed in various adipose tissues, whose tissue-specific upregulation was induced during the development of obesity. These data suggest that AM may act as a new member of adipokines, although its functional role, as well as its pathophysiological significance in obesity, remains to be determined.Keywords
This publication has 37 references indexed in Scilit:
- Coexpression of Calcitonin Receptor-Like Receptor and Receptor Activity-Modifying Protein 2 or 3 Mediates the Antimigratory Effect of AdrenomedullinEndocrinology, 2003
- Adrenomedullin has multiple roles in disease stress: Development and remission of the inflammatory responseMicroscopy Research and Technique, 2002
- The adipocyte: a model for integration of endocrine and metabolic signaling in energy metabolism regulationAmerican Journal of Physiology-Endocrinology and Metabolism, 2001
- Obesity and insulin resistanceJCI Insight, 2000
- Adrenomedullin as a Novel Growth-Promoting Factor for Cultured Vascular Smooth Muscle Cells: Role of Tyrosine Kinase-Mediated Mitogen-Activated Protein Kinase Activation1Endocrinology, 1998
- Plasma Adrenomedullin Levels in Type 1 Diabetes: Relationship with clinical parametersDiabetes Care, 1998
- Plasma adrenomedullin in diabetesThe Lancet, 1997
- Increased circulating adrenomedullin, a novel vasodilatory peptide, in sepsis.Journal of Clinical Endocrinology & Metabolism, 1996
- Adrenomedullin as a Novel Antimigration Factor of Vascular Smooth Muscle CellsCirculation Research, 1995
- Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin ResistanceScience, 1993